Windtree Therapeutics Inc (NASDAQ:WINT) does about 2.74M shares in volume on a normal day but saw 1525710 shares change hands in the recent trading day. The company now has a market cap of 2.89M USD. Its current market price is $0.79, marking an increase of 5.36% compared to the previous close of $0.75. The 52 week high reached by this stock is $737.43 whilst the lowest price level in 52 weeks is $0.67.
The consensus objective for the share price is $4.00, suggesting that the stock has a potential upside of 80.25% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Hold the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 26, 2020 when Ladenburg Thalmann initiated the stock to “Buy” and issued a price target of $12.25.
The current price level is -4.02%, -27.60%, and -98.66% away from its SMA20, SMA50, and SMA200 respectively, with the WINT price moving above the 50-day SMA on current market day. Windtree Therapeutics Inc (WINT) stock is down -1.13% over the week and -20.64% over the past month. Its price is -95.48% year-to-date and -99.57% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and -486.5 for whole year.
To reach the target analysts have set, the stock logically needs to grow 80.25 percent from here.
Outstanding shares total 3.56M with insiders holding 0.01% of the shares and institutional holders owning 1.40% of the company’s common stock. The company has a return on investment of -175.14% and return on equity of -120.01%. The beta has a value of 0.76. Price to book ratio is 0.27.
